Please assess the completion status of the following clinical trial:

Trial Title: Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* over 20 years old~* patients with triple negative breast cancer diagnosed Seoul National University Hospital~* patients who decided to perform neoadjuvant chemotherapy under clinical judgement~Exclusion Criteria:~* not applicable

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: None

Study Arms:
- metaplastic breast cancer (Type: None): Histologically determined to be a metaplastic breast cancer or tested positive for vimentin/Pan CK patients decides as the metaplastic breast cancer.
- non-metaplastic breast cancer (Type: None): Patients with vimentin/Pan CK negative are diagnosed with non-metaplastic breast cancer

Based on this trial design, predict the completion outcome and termination type (if applicable).